108 related articles for article (PubMed ID: 26474899)
1. Optimizing outcomes after coronary artery bypass grafting: The argument for dual antiplatelet therapy.
Halkos ME
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1555-6. PubMed ID: 26474899
[No Abstract] [Full Text] [Related]
2. Dual antiplatelet therapy use by Canadian cardiac surgeons.
Yanagawa B; Ruel M; Bonneau C; Lee MM; Chung J; Al Shouli S; Fagan A; Al Khalifa A; White CW; Yamashita MH; Currie ME; Teoh H; Mewhort HE; Verma S
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1548-54.e3. PubMed ID: 26395051
[TBL] [Abstract][Full Text] [Related]
3. Pattern and predictors of dual antiplatelet use after coronary artery bypass graft surgery.
Mori M; Shioda K; Yun JJ; Mangi AA; Darr U; Geirsson A
J Thorac Cardiovasc Surg; 2018 Feb; 155(2):632-638. PubMed ID: 29056263
[TBL] [Abstract][Full Text] [Related]
4. Contemporary audit of antiplatelet therapy prescribing patterns following coronary artery bypass grafting.
Wei D; Wang TKM
N Z Med J; 2019 Jul; 132(1498):100-104. PubMed ID: 31295243
[No Abstract] [Full Text] [Related]
5. Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.
Nocerino AG; Achenbach S; Taylor AJ
Am J Cardiol; 2013 Nov; 112(10):1576-9. PubMed ID: 24035160
[TBL] [Abstract][Full Text] [Related]
6. [Editorial comment: distribution of therapeutic procedures and drug selection in coronary artery disease].
Akgün G
Anadolu Kardiyol Derg; 2002 Mar; 2(1):24-5. PubMed ID: 12793430
[No Abstract] [Full Text] [Related]
7. Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.
Fauchier L; Greenlaw N; Ferrari R; Ford I; Fox KM; Tardif JC; Tendera M; Steg PG;
PLoS One; 2015; 10(4):e0125164. PubMed ID: 25915904
[TBL] [Abstract][Full Text] [Related]
8. Physician billing and cardiac stress testing patterns.
Vazquez-Bauza JJ
JAMA; 2012 Feb; 307(8):782; author reply 782-3. PubMed ID: 22357825
[No Abstract] [Full Text] [Related]
9. Physician billing and cardiac stress testing patterns.
Pellikka PA; McCully RB
JAMA; 2012 Feb; 307(8):781; author reply 782-3. PubMed ID: 22357824
[No Abstract] [Full Text] [Related]
10. Impact of preoperative antiplatelet therapy on in-hospital outcomes after coronary artery bypass grafting.
Rubino AS; Della Corte A; Giordano R; Menicanti L;
Eur J Cardiothorac Surg; 2014 Aug; 46(2):335. PubMed ID: 24523496
[No Abstract] [Full Text] [Related]
11. Low-volume coronary artery bypass surgery: measuring and optimizing performance.
Shahian DM; Normand SL
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1202-9. PubMed ID: 18544354
[No Abstract] [Full Text] [Related]
12. ICVTS on-line discussion A. Anatomofunctional information is obligatory for CAD patients.
Bockeria LA; Berishvili I
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):302-3; discussion 303. PubMed ID: 17669850
[No Abstract] [Full Text] [Related]
13. Hybrid coronary revascularization: an overview of options for anticoagulation and platelet inhibition.
Zimrin D; Bonatti J; Vesely MR; Lehr EJ
Heart Surg Forum; 2010 Dec; 13(6):E405-8. PubMed ID: 21169155
[TBL] [Abstract][Full Text] [Related]
14. Dual antiplatelet therapy at discharge: Antiplatelet practice patterns after coronary artery bypass grafting, surgical anecdote is driving standard of care.
Helmers M; Atluri P
J Thorac Cardiovasc Surg; 2018 Feb; 155(2):639-640. PubMed ID: 29198798
[No Abstract] [Full Text] [Related]
15. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group.
Goodnough LT; Johnston MF; Toy PT
JAMA; 1991 Jan; 265(1):86-90. PubMed ID: 1984129
[TBL] [Abstract][Full Text] [Related]
16. Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting.
Gasparovic H; Petricevic M; Kopjar T; Djuric Z; Svetina L; Biocina B
Am J Cardiol; 2014 May; 113(10):1660-7. PubMed ID: 24666617
[TBL] [Abstract][Full Text] [Related]
17. Cardiac procedures, outcomes, and accountability.
Krumholz HM
N Engl J Med; 1997 May; 336(21):1522-3. PubMed ID: 9154775
[No Abstract] [Full Text] [Related]
18. Rationale and design of a randomized cluster trial to improve guideline-adherence of secondary preventive drugs prescription after coronary artery bypass grafting in China: Measurement and Improvement Studies of Surgical Coronary Revascularization: Secondary Prevention (MISSION-1) Study.
Rao C; Du J; Li X; Li J; Zhang H; Zhao Y; Hu S; Jiang L; Zheng Z;
Am Heart J; 2016 Aug; 178():9-18. PubMed ID: 27502847
[TBL] [Abstract][Full Text] [Related]
19. Selecting the ideal cardiovascular surgeon: is it possible with public dissemination of clinical outcomes?
Canto JG
Med Care; 2007 Jul; 45(7):585-6. PubMed ID: 17571005
[No Abstract] [Full Text] [Related]
20. To treat the patient or to treat the surgeon.
Myhre BA
JAMA; 1991 Jan; 265(1):97-8. PubMed ID: 1984132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
